ACADIA Pharmaceuticals Inc. (ACAD) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 33.98M | -48.73M | 74.29M | 63.96M | 20.32M | 40.38M | 63.25M | 25.01M | 29.08M | 85.39M | -58.95M | 8.2M | -17.93M | -23.85M | -727K | -13.13M | -76.33M | -23.12M | -17.06M | -25.33M |
| Operating CF Margin % | 12.68% | -17.16% | 26.66% | 24.17% | 8.32% | 15.55% | 25.26% | 10.34% | 14.13% | 36.96% | -27.85% | 4.96% | -15.14% | -17.48% | -0.56% | -9.75% | -66.1% | -17.68% | -12.97% | -21.98% |
| Operating CF Growth % | 67.2% | -220.68% | 17.46% | 155.69% | -30.11% | -52.71% | 207.28% | 205% | 262.15% | 457.97% | -8009.35% | 162.48% | 76.51% | -3.17% | 95.74% | 48.18% | -26.9% | 15.89% | 25.13% | 31.33% |
| Net Income | 3.64M | 273.57M | 71.78M | 26.67M | 18.99M | 143.74M | 32.77M | 33.39M | 16.55M | 45.8M | -65.18M | 1.11M | -43.02M | -41.73M | -27.18M | -34.01M | -113.06M | -43.09M | -14.46M | -43.87M |
| Depreciation & Amortization | 2.99M | 2.92M | 2.95M | -1.16M | 2.95M | 5.21M | 2.57M | 2.57M | 5.53M | 1.64M | 1.72M | 1.77M | 426K | 489K | 506K | 515K | 516K | 535K | 985K | 929K |
| Stock-Based Compensation | 0 | 0 | 13.18M | 14.34M | 11.38M | 10.45M | 26.16M | 15.69M | 14.75M | 18.02M | 18.54M | 15.15M | 14.71M | 14.41M | 18.31M | 20.51M | 14.96M | 12.88M | 15.55M | 22M |
| Deferred Taxes | -94K | -249.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 14.24M | 12.56M | -1.1M | 2.56M | -2.12M | -149.33M | -2.75M | -1.95M | -1.79M | -1.78M | 46.59M | -247K | -6.61M | -3.64M | -3.35M | 597K | 108K | -985K | 207K | 309K |
| Working Capital Changes | 13.2M | -87.91M | -12.52M | 21.55M | -10.88M | 30.31M | 4.49M | -24.68M | -5.97M | 21.71M | -10.56M | -9.59M | 16.56M | 6.61M | 10.98M | -738K | 21.14M | 7.54M | -19.34M | -4.7M |
| Change in Receivables | -153K | -8.8M | -19.75M | -5.97M | -9.02M | 5.67M | 30K | -10.31M | 2.27M | -7.82M | -10.95M | -13.91M | -7.17M | -6.94M | 12.75M | -5.41M | 1.86M | -3.68M | -9.85M | 5.57M |
| Change in Inventory | 78K | -4.89M | 1.25M | -4.1M | -10.45M | -4.42M | -1.33M | -27.15M | -16.65M | -15.07M | -11.22M | -3M | 481K | 310K | 640K | 632K | 833K | 217K | -3.55M | -386K |
| Change in Payables | 1.34M | -10.84M | 1.65M | 2M | 1.9M | -2.89M | -801K | 550K | 1.79M | 5.23M | -6.5M | 1.39M | 4.68M | 2.74M | -1.85M | 1.09M | 3.89M | -846K | -1.34M | 216K |
| Cash from Investing | 66.28M | -55.87M | -79.35M | -43.29M | -124.05M | 122.15M | -82.46M | -56.19M | -14.04M | -347K | 34.11M | -194.28M | 192.52M | -17.75M | 15.44M | -55.8M | 131.34M | 71.55M | -156.32M | -17.21M |
| Capital Expenditures | -5.21M | -4M | -388K | 98.54M | -98.84M | -453K | -70K | 0 | 0 | 0 | -50K | -40M | 0 | 0 | 0 | 0 | 0 | -1K | 0 | -45K |
| CapEx % of Revenue | 1.94% | 1.41% | 0.14% | 37.25% | 40.45% | 0.17% | 0.03% | - | - | - | 0.02% | 24.21% | - | - | - | - | - | 0% | - | 0.04% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -98.84M | 0 | 146.51M | 0 | 0 | 0 | 0 | -50K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 4.23M | 22.67M | 9.42M | 15.96M | 1.84M | 1.97M | 268K | 3.56M | 1.04M | 5.43M | 12.75M | 5.48M | 1.47M | 1.61M | 287K | 3.83M | 2.47M | 4.37M | 1.07M | 5M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 4.23M | 22.67M | 9.42M | 15.96M | 1.84M | 1.97M | 268K | 3.56M | 1.04M | 5.43M | 12.75M | 5.48M | 1.47M | 1.61M | 287K | 3.83M | 2.47M | 4.37M | 1.07M | 5M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 104.52M | -80.3M | 4.36M | 36.64M | -101.89M | 164.44M | -18.98M | -27.61M | 16.09M | 90.46M | -12.1M | -182.95M | 176.05M | -40M | 15.01M | -65.09M | 57.48M | 52.8M | -172.32M | -37.53M |
| Free Cash Flow | 28.77M | -52.74M | 73.9M | 162.5M | -78.52M | 39.93M | 63.18M | 25.01M | 29.08M | 85.39M | -59.01M | 8.2M | -17.93M | -23.85M | -727K | -13.13M | -76.33M | -23.12M | -17.06M | -25.37M |
| FCF Margin % | 10.73% | -18.57% | 26.52% | 61.42% | -32.14% | 15.38% | 25.23% | 10.34% | 14.13% | 36.96% | -27.87% | 4.96% | -15.14% | -17.48% | -0.56% | -9.75% | -66.1% | -17.68% | -12.97% | -22.02% |
| FCF Growth % | 136.64% | -232.08% | 16.97% | 549.65% | -370.01% | -53.24% | 207.07% | 205% | 262.15% | 457.97% | -8016.23% | 162.48% | 76.51% | -3.17% | 95.74% | 48.27% | -24.67% | 21.59% | 30.39% | 36.28% |
| FCF per Share | 0.17 | -0.31 | 0.43 | 0.96 | -0.47 | 0.24 | 0.38 | 0.15 | 0.17 | 0.51 | -0.36 | 0.05 | -0.11 | -0.15 | -0.00 | -0.08 | -0.47 | -0.14 | -0.11 | -0.16 |
| FCF Conversion (FCF/Net Income) | 9.34x | -0.18x | 1.03x | 2.40x | 1.07x | 0.28x | 1.93x | 0.75x | 1.76x | 1.86x | 0.90x | 7.36x | 0.42x | 0.57x | 0.03x | 0.39x | 0.68x | 0.54x | 1.18x | 0.58x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |